KRAS inhibitors, approved

被引:21
作者
Rosell, Rafael [1 ,2 ,3 ]
Aguilar, Andres [2 ]
Pedraz, Carlos [3 ]
Chaib, Imane [3 ]
机构
[1] Catalan Inst Oncol, Badalona, Spain
[2] Oncol Inst Dr Rosell, IOR, Barcelona, Spain
[3] Germans Trias & Pujol Res Inst IGTP, Badalona, Spain
基金
欧盟地平线“2020”;
关键词
KRAS(G12C);
D O I
10.1038/s43018-021-00289-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rapid progression of KRAS(G12C) inhibitors from preclinical characterization to the clinic has radically changed the perception of the KRAS oncogene as an undruggable target. Here we discuss ongoing and future possibilities for developing therapies using these inhibitors in clinical settings.
引用
收藏
页码:1254 / 1256
页数:3
相关论文
共 11 条
[1]   Acquired Resistance to KRASG12C Inhibition in Cancer [J].
Awad, M. M. ;
Liu, S. ;
Rybkin, I. I. ;
Arbour, K. C. ;
Dilly, J. ;
Zhu, V. W. ;
Johnson, M. L. ;
Heist, R. S. ;
Patil, T. ;
Riely, G. J. ;
Jacobson, J. O. ;
Yang, X. ;
Persky, N. S. ;
Root, D. E. ;
Lowder, K. E. ;
Feng, H. ;
Zhang, S. S. ;
Haigis, K. M. ;
Hung, Y. P. ;
Sholl, L. M. ;
Wolpin, B. M. ;
Wiese, J. ;
Christiansen, J. ;
Lee, J. ;
Schrock, A. B. ;
Lim, L. P. ;
Garg, K. ;
Li, M. ;
Engstrom, L. D. ;
Waters, L. ;
Lawson, J. D. ;
Olson, P. ;
Lito, P. ;
Ou, S. -H. I. ;
Christensen, J. G. ;
Janne, P. A. ;
Aguirre, A. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) :2382-2393
[2]   KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors [J].
Hong, David S. ;
Fakih, Marwan G. ;
Strickler, John H. ;
Desai, Jayesh ;
Durm, Gregory A. ;
Shapiro, Geoffrey I. ;
Falchook, Gerald S. ;
Price, Timothy J. ;
Sacher, Adrian ;
Denlinger, Crystal S. ;
Bang, Yung-Jue ;
Dy, Grace K. ;
Krauss, John C. ;
Kuboki, Yasutoshi ;
Kuo, James C. ;
Coveler, Andrew L. ;
Park, Keunchil ;
Kim, Tae Won ;
Barlesi, Fabrice ;
Munster, Pamela N. ;
Ramalingam, Suresh S. ;
Burns, Timothy F. ;
Meric-Bernstam, Funda ;
Henary, Haby ;
Ngang, Jude ;
Ngarmchamnanrith, Gataree ;
Kim, June ;
Houk, Brett E. ;
Canon, Jude ;
Lipford, J. Russell ;
Friberg, Gregory ;
Lito, Piro ;
Govindan, Ramaswamy ;
Li, Bob T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (13) :1207-1217
[3]   Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients [J].
Kim, Dongsung ;
Xue, Jenny Yaohua ;
Lito, Piro .
CELL, 2020, 183 (04) :850-859
[4]   KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments [J].
Koga, Takamasa ;
Suda, Kenichi ;
Fujino, Toshio ;
Ohara, Shuta ;
Hamada, Akira ;
Nishino, Masaya ;
Chiba, Masato ;
Shimoji, Masaki ;
Takemoto, Toshiki ;
Arita, Takeo ;
Gmachl, Michael ;
Hofmann, Marco H. ;
Soh, Junichi ;
Mitsudomi, Tetsuya .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) :1321-1332
[5]   The ERBB network facilitates KRAS-driven lung tumorigenesis [J].
Kruspig, Bjorn ;
Monteverde, Tiziana ;
Neidler, Sarah ;
Hock, Andreas ;
Kerr, Emma ;
Nixon, Colin ;
Clark, William ;
Hedley, Ann ;
Laing, Sarah ;
Coffelt, Seth B. ;
Le Quesne, John ;
Dick, Craig ;
Vousden, Karen ;
Martins, Carla P. ;
Murphy, Daniel J. .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (446)
[6]   The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS [J].
Li, Chuanchuan ;
Vides, Alberto ;
Kim, Dongsung ;
Xue, Jenny Y. ;
Zhao, Yulei ;
Lito, Piro .
SCIENCE, 2021, 374 (6564) :197-+
[7]   KRASG12C inhibition produces a driver-limited state revealing collateral dependencies [J].
Lou, Kevin ;
Steri, Veronica ;
Ge, Alex Y. ;
Hwang, Y. Christina ;
Yogodzinski, Christopher H. ;
Shkedi, Arielle R. ;
Choi, Alex L. M. ;
Mitchell, Dominique C. ;
Swaney, Danielle L. ;
Hann, Byron ;
Gordan, John D. ;
Shokat, Kevan M. ;
Gilbert, Luke A. .
SCIENCE SIGNALING, 2019, 12 (583)
[8]   A combinatorial strategy for treating KRAS-mutant lung cancer [J].
Manchado, Eusebio ;
Weissmueller, Susann ;
Morris, John P. ;
Chen, Chi-Chao ;
Wullenkord, Ramona ;
Lujambio, Amaia ;
de Stanchina, Elisa ;
Poirier, John T. ;
Gainor, Justin F. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. ;
Rudin, Charles M. ;
Rosen, Neal ;
Lowe, Scott W. .
NATURE, 2016, 534 (7609) :647-+
[9]   Sotorasib for Lung Cancers with KRAS p.G12C Mutation [J].
Skoulidis, Ferdinandos ;
Li, Bob T. ;
Dy, Grace K. ;
Price, Timothy J. ;
Falchook, Gerald S. ;
Wolf, Jurgen ;
Italiano, Antoine ;
Schuler, Martin ;
Borghaei, Hossein ;
Barlesi, Fabrice ;
Kato, Terufumi ;
Curioni-Fontecedro, Alessandra ;
Sacher, Adrian ;
Spira, Alexander ;
Ramalingam, Suresh S. ;
Takahashi, Toshiaki ;
Besse, Benjamin ;
Anderson, Abraham ;
Ang, Agnes ;
Tran, Qui ;
Mather, Omar ;
Henary, Haby ;
Ngarmchamnanrith, Gataree ;
Friberg, Gregory ;
Velcheti, Vamsidhar ;
Govindan, Ramaswamy .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) :2371-2381
[10]   Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules [J].
Tulpule, Asmin ;
Guan, Juan ;
Neel, Dana S. ;
Allegakoen, Hannah R. ;
Lin, Yone Phar ;
Brown, David ;
Chou, Yu-Ting ;
Heslin, Ann ;
Chatterjee, Nilanjana ;
Perati, Shriya ;
Menon, Shruti ;
Nguyen, Tan A. ;
Debnath, Jayanta ;
Ramirez, Alejandro D. ;
Shi, Xiaoyu ;
Yang, Bin ;
Feng, Siyu ;
Makhija, Suraj ;
Huang, Bo ;
Bivona, Trever G. .
CELL, 2021, 184 (10) :2649-+